Form 4 Filing for Nutex Health Inc.

This filing details a transaction by Scott J. Saunders, a director at Nutex Health Inc. On July 31, 2026, Mr. Saunders acquired 603 shares of Common Stock through the conversion of restricted stock units, with the transaction code 'M' indicating a None-derivative disposition. The acquisition was made at a price of $0.0 per share, as noted by a footnote referencing the conversion of RSUs. Following this transaction, Mr. Saunders holds a total of 603 shares directly. The filing also confirms that the transaction was reported on the required form and that the reporting owner is not subject to Section 16 of the Securities Exchange Act of 1934.